Metabolic disorders, COVID-19 and vaccine-breakthrough infections

Global pandemics interconnected — obesity, impaired metabolic health and COVID-19

(2021) Norbert Stefan et al.   Nature Reviews Endocrinology

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

(2021) Madhumita Shrotri et al.   LANCET

Hospitalisation among vaccine breakthrough COVID-19 infections

(2021) Prerak V Juthani et al.   LANCET INFECTIOUS DISEASES

Mapping the human genetic architecture of COVID-19

(2021)   NATURE

Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study

(2021) Min Gao et al.   Lancet Diabetes & Endocrinology

Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19

(2021) Jihoon Shin et al.   DIABETES

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study

(2021) Utkarsh Agrawal et al.   Lancet Respiratory Medicine

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

(2020) Ana Campos Codo et al.   Cell Metabolism

Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection

(2018) Sue Tsai et al.   Cell Metabolism